Tag: nuclear imaging and neuroendocrine tumors

Gallium 68 PET/CT Scanning for Neuroendocrine Tumors — Information and Locations

April 6, 2017

The US Food and Drug Administration’s (FDA) June 1, 2016 approval of the Gallium-68 PET/CT DOTATATE scan using NETSPOT® heralded a new age of nuclear imaging for neuroendocrine tumors in the United States.

PLEASE SCROLL DOWN FOR A STATE-BY STATE LISTREAD MORE
3rd Theranostics World Congress

3rd Theranostics World Congress Offers Free Patient Program on March 14

February 27, 2015

Johns Hopkins University in Baltimore, Maryland will be the site of the 3rd Theranostics World Congress on Ga-68 & PRRT from March 12-14, 2015. Co-sponsored by the Society of Nuclear Medicine and Molecular Imaging and Johns Hopkins Medicine, the…

READ MORE
Society of Nuclear Medicine and Molecular Imaging, Patient Program, June 9, 2013, Vancouver, Canada

Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging Patient Program

May 22, 2013

Josh Mailman, President of the NorCal CarciNET support group and Chair of the Patient Advocate Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day …

READ MORE
Chateau Laurier, Conference Center

2012 CNETS Canada Carcinoid and Neuroendocrine Conference Joins Medical Professionals, Patients & Caregivers

February 5, 2012

Carcinoid cancer and neuroendocrine tumor specialists from around the world, fascinating presentations on all aspects of these rare diseases, the opportunity to meet fellow carcinoid and neuroendocrine tumor (NETs)  patients and caregivers …

READ MORE